CARMOT THERAPEUTICS INC.

Profile

Company Names

CARMOT THERAPEUTICS INC.

Addresses

740 HEINZ AVENUE, BERKELEY, CA 94710

409 ILLINOIS STREET, SAN FRANCISCO, CA 94158

Phone Numbers

510-828-0102

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$349,799,919.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-05-24 
$149,999,802.00 
$149,999,802.00 
$0.00 
Equity 
5
2022-07-25 
$160,671,809.00 
$160,671,809.00 
$0.00 
Equity 
4
2020-09-17 
$26,282,207.00 
$46,882,157.00 
$20,599,950.00 
Equity 
3
2017-08-11 
$10,795,943.00 
$15,374,764.00 
$4,578,821.00 
Equity 
2
2012-06-28 
$500,159.00 
$1,200,317.00 
$700,158.00 
Equity 
1
2010-04-07 
$1,549,999.00 
$1,549,999.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
A. 
ERLANSON 
EXECUTIVE OFFICER, DIRECTOR
CARMOT THERAPEUTICS INC.
TIMOTHY 
 
GARNETT 
DIRECTOR
OPHIREX, INC.   |  CARMOT THERAPEUTICS INC.   |  MAPLIGHT THERAPEUTICS, INC.
DAVE 
 
GOEDDEL 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  FLEXUS BIOSCIENCES, INC.
STIG 
K. 
HANSEN 
EXECUTIVE OFFICER, DIRECTOR
CARMOT THERAPEUTICS INC.
STIG 
K. 
HANSEN, PH.D. 
DIRECTOR
CARMOT THERAPEUTICS INC.
TIM 
 
KUTZKEY 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  CYTERIX PHARMACEUTICALS INC.   |  PELOTON THERAPEUTICS, INC.   |  NEURONA THERAPEUTICS INC   |  KALLYOPE, INC.   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  SURROZEN, INC.   |  NEURONA THERAPEUTICS, INC   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  SITE TX, INC.   |  NILO THERAPEUTICS, INC.   |  NGM BIO HOLDINGS, INC.
TIM 
 
KUTZKY 
DIRECTOR
CARMOT THERAPEUTICS INC.
LARRY 
 
LASKY 
DIRECTOR
ONCOMED PHARMACEUTICALS INC   |  CARMOT THERAPEUTICS INC.
MAGNUS 
 
PERSSON 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  CERECOR INC.   |  GOLDCUP 12446 AB   |  TRAILHEAD BIOSYSTEMS INC.
ANNE 
 
PHILLIPS, M.D. 
DIRECTOR
CARMOT THERAPEUTICS INC.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
AETNA 
WUN 
TROMBLEY 
DIRECTOR
CARMOT THERAPEUTICS INC.
AETNA WUN 
 
TROMBLEY 
DIRECTOR
CARMOT THERAPEUTICS INC.   |  LYCIA THERAPEUTICS, INC.
HEATHER 
 
TURNER 
EXECUTIVE OFFICER, DIRECTOR
AGRE DCP OAKLAND CITY CENTER REIT LLC   |  AGRE DCP PALM SPRINGS REIT LLC   |  CERO THERAPEUTICS, INC.   |  LYELL IMMUNOPHARMA, INC.   |  CARMOT THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-24 
2022-08-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-07-25 
2020-10-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-17 
2017-08-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-11 
2012-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-28 
2010-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#